246 related articles for article (PubMed ID: 11016524)
1. Dual diagnosis in the suburbs: prevalence, need, and in-patient service use.
Wright S; Gournay K; Glorney E; Thornicroft G
Soc Psychiatry Psychiatr Epidemiol; 2000 Jul; 35(7):297-304. PubMed ID: 11016524
[TBL] [Abstract][Full Text] [Related]
2. Drug and alcohol problems among individuals with severe mental illness in south London.
Menezes PR; Johnson S; Thornicroft G; Marshall J; Prosser D; Bebbington P; Kuipers E
Br J Psychiatry; 1996 May; 168(5):612-9. PubMed ID: 8733801
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.
Miles H; Johnson S; Amponsah-Afuwape S; Finch E; Leese M; Thornicroft G
Psychiatr Serv; 2003 Apr; 54(4):554-61. PubMed ID: 12663845
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of substance misuse among individuals with severe mental illness in São Paulo.
Rossi Menezes P; Ratto LR
Soc Psychiatry Psychiatr Epidemiol; 2004 Mar; 39(3):212-7. PubMed ID: 14999454
[TBL] [Abstract][Full Text] [Related]
5. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough.
Weaver T; Rutter D; Madden P; Ward J; Stimson G; Renton A
Soc Psychiatry Psychiatr Epidemiol; 2001 Aug; 36(8):399-406. PubMed ID: 11766970
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric Hospitalizations of Chronic Psychotic Disorder Patients With and Without Dual Diagnosis, Israel, 1963-2016.
Florentin S; Rosca P; Raskin S; Bdolah-Abram T; Neumark Y
J Dual Diagn; 2019; 15(3):130-139. PubMed ID: 31079564
[No Abstract] [Full Text] [Related]
7. Addiction Vulnerability: Exploring Relationships Among Cigarette Smoking, Substance Misuse, and Early Psychosis.
Clark V; Conrad AM; Lewin TJ; Baker AL; Halpin SA; Sly KA; Todd J
J Dual Diagn; 2018; 14(2):78-88. PubMed ID: 29261427
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of substance misuse in first-episode psychosis.
Cantwell R; Brewin J; Glazebrook C; Dalkin T; Fox R; Medley I; Harrison G
Br J Psychiatry; 1999 Feb; 174():150-3. PubMed ID: 10211169
[TBL] [Abstract][Full Text] [Related]
9. Substance misuse at presentation to an early psychosis program.
Van Mastrigt S; Addington J; Addington D
Soc Psychiatry Psychiatr Epidemiol; 2004 Jan; 39(1):69-72. PubMed ID: 15022049
[TBL] [Abstract][Full Text] [Related]
10. How does drug and alcohol misuse develop among people with psychotic illness? A literature review.
Phillips P; Johnson S
Soc Psychiatry Psychiatr Epidemiol; 2001 Jun; 36(6):269-76. PubMed ID: 11583456
[TBL] [Abstract][Full Text] [Related]
11. Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.
Carrà G; Johnson S
Soc Psychiatry Psychiatr Epidemiol; 2009 Jun; 44(6):429-47. PubMed ID: 19011722
[TBL] [Abstract][Full Text] [Related]
12. Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms.
Kamali M; McTigue O; Whitty P; Gervin M; Clarke M; Browne S; Larkin C; O'Callaghan E
Early Interv Psychiatry; 2009 Aug; 3(3):198-203. PubMed ID: 22640383
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry.
Lecomte T; Giguère CÉ; Cloutier B; Potvin S;
J Dual Diagn; 2020; 16(2):260-270. PubMed ID: 31983294
[No Abstract] [Full Text] [Related]
14. Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study.
Ringen PA; Melle I; Birkenaes AB; Engh JA; Faerden A; Jónsdóttir H; Nesvåg R; Vaskinn A; Friis S; Larsen F; Opjordsmoen S; Sundet K; Andreassen OA
Acta Psychiatr Scand; 2008 Feb; 117(2):133-8. PubMed ID: 18081921
[TBL] [Abstract][Full Text] [Related]
15. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
[TBL] [Abstract][Full Text] [Related]
16. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
17. [Dual diagnosis in psychoactive substance abusing or dependent persons].
Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
[TBL] [Abstract][Full Text] [Related]
18. Dual diagnosis in an Australian forensic psychiatric hospital: prevalence and implications for services.
Ogloff JR; Lemphers A; Dwyer C
Behav Sci Law; 2004; 22(4):543-62. PubMed ID: 15282839
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services.
Weaver T; Madden P; Charles V; Stimson G; Renton A; Tyrer P; Barnes T; Bench C; Middleton H; Wright N; Paterson S; Shanahan W; Seivewright N; Ford C;
Br J Psychiatry; 2003 Oct; 183():304-13. PubMed ID: 14519608
[TBL] [Abstract][Full Text] [Related]
20. [Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].
Gouzoulis-Mayfrank E
Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):245-53. PubMed ID: 18654956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
